| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |